Publications

November 6, 2018

Immunogenicity, safety and tolerability of the Measles-vectored Chikungunya vaccine MV-CHIK: A double-blind, randomised, placebo- and Priorix-controlled Phase 2 trial

more
December 5, 2016

Chikungunya Virus Vaccines: Viral Vector–Based Approaches

more
March 1, 2015

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial

more